X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Aventis Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aventis Pharma Quarterly Results   (HOCM)

Here are the latest quarterly results of Aventis Pharma. For more details, see the Aventis Pharma financial fact sheet and Aventis Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Aventis Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-16
3
Sep-16
3
Mar-17
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m6,0806,2425,5296,0066,6756,7046,1776,836 
Other income Rs m164148159284208182226208 
Turnover Rs m6,2446,3905,6886,2906,8836,8866,4037,044 
Expenses Rs m4,6224,7954,5144,8524,8385,3604,8335,191 
Gross profit Rs m1,4581,4471,0151,1541,8371,3441,3441,645 
Depreciation Rs m300300253255257257254254 
Interest Rs m734001100 
Profit before tax Rs m1,3151,2929171,1831,7881,2581,3161,599 
Tax Rs m462486317446625498491603 
Profit after tax Rs m8538066007371,163760825996 
Gross profit margin %24.023.218.419.227.520.021.824.1 
Effective tax rate %35.137.634.637.735.039.637.337.7 
Net profit margin %14.012.910.912.317.411.313.414.6 
Diluted EPS Rs 37.0 35.0 26.1 32.0 50.5 33.0 35.8 43.2  
Diluted EPS (TTM) Rs 126.3 129.8 133.1 130.1 143.6 141.6 151.3 162.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Aventis Pharma 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   J.B.CHEMICALS  GSK PHARMA  CIPLA  ORCHID PHARMA LTD  GLENMARK PHARMA  

Compare SANOFI INDIA With:   J.B.CHEMICALS  GSK PHARMA  CIPLA  ORCHID PHARMA LTD  GLENMARK PHARMA  

Compare SANOFI INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Views on news

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY18); Net Profit Up 37.5% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SANOFI INDIA has posted a net profit of Rs 825 m (up 37.5% YoY). Sales on the other hand came in at Rs 6 bn (up 11.7% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 17, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA - DIVIS LABORATORIES COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS